Morganella morganii

Revisión del 01:02 28 ene 2026 de Ostermayer (discusión | contribs.) (Created page with "==Background== *Gram-negative, facultative anaerobic rod *Member of the tribe Proteeae (along with ''Proteus'' and ''Providencia'') *Important cause of nosocomial infections, particularly CAUTIs *Typically affects immunocompromised, elderly, or nursing home residents *Possesses chromosomal AmpC $\beta$-lactamase (inducible resistance) ==Clinical Features== *Urinary Tract Infection **Most common presentation **Often ass...")
(difs.) ← Revisión anterior | Revisión actual (difs.) | Revisión siguiente → (difs.)

Background

  • Gram-negative, facultative anaerobic rod
  • Member of the tribe Proteeae (along with Proteus and Providencia)
  • Important cause of nosocomial infections, particularly CAUTIs
  • Typically affects immunocompromised, elderly, or nursing home residents
  • Possesses chromosomal AmpC $\beta$-lactamase (inducible resistance)

Clinical Features

Differential Diagnosis

Dysuria

Evaluation

  • Urinalysis: Alkaline pH (often > 7.5 due to urease)
  • CBC: Leukocytosis
  • Lactate: Elevated in sepsis
  • Blood Cx: Mandatory if febrile or hypothermic
  • Imaging:
    • CT KUB if concern for struvite stones/obstruction
    • CT Soft Tissue if concern for necrotizing fasciitis (snake bite/wound)

Management

  • Source control
    • Remove/replace indwelling urinary catheter
    • Debridement of infected wounds/bites
  • Antibiotic considerations relating to AmpC $\beta$-lactamase
    • Intrinsic resistance to many $\beta$-lactams
    • Avoid first/second generation cephalosporins and ampicillin
    • Inducible resistance may occur with 3rd generation cephalosporins (Ceftriaxone)
  • Preferred agents: Carbapenems, Cefepime, Fluoroquinolones, or Aminoglycosides

Antibiotic Sensitivities[1]

Category Antibiotic Sensitivity
Penicillins Penicillin G R
Penicillin V R
Anti-Staphylocccal Penicillins Methicillin R
Nafcillin/Oxacillin R
Amino-Penicillins AMP/Amox R
Amox-Clav R
AMP-Sulb R
Anti-Pseudomonal Penicillins Ticarcillin S
Pip-Tazo S
Piperacillin S
Carbapenems Doripenem S
Ertapenem S
Imipenem S
Meropenem S
Aztreonam S
Fluoroquinolones Ciprofloxacin S
Levofloxacin S
Moxifloxacin S
1st G Cephalo Cefazolin R
Cephalexin R
2nd G. Cephalo Cefotetan R
Cefoxitin R
Cefuroxime R
3rd G. Cephalo Cefotaxime X1
CefTRIAXone X1
CefTAZidime S
Cefdinir X1
4th G. Cephalo Cefepime S
Aminoglycosides Gentamicin S
Tobramycin S
Amikacin S
Clindamycin R
Macrolides Erythromycin R
Azithromycin R
Tetracyclines Doxycycline X1
Tigecycline R
Glyco/Lipoglycopeptides Vancomycin R
Daptomycin R
Urinary Agents Nitrofurantoin R
Fosfomycin R
Other Trimethoprim R
TMP-SMX S
Metronidazole R
Linezolid R
Colistimethate R
Polymyxin B R

Key

  • S susceptible/sensitive (usually)
  • I intermediate (variably susceptible/resistant)
  • R resistant (or not effective clinically)
  • S+ synergistic with cell wall antibiotics
  • U sensitive for UTI only (non systemic infection)
  • X1 no data
  • X2 active in vitro, but not used clinically
  • X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
  • X4 active in vitro, but not clinically effective for strep pneumonia
  • Note: Morganella has intrinsic resistance to Oxacillin, Ampicillin, Amoxicillin, most 1st/2nd Gen Cephalosporins, Macrolides, Lincosamides, Glycopeptides, Nitrofurantoin, and Polymyxins (Colistin).

Table Overview

References

  1. Sanford Guide to Antimicrobial Therapy

See Also

References